Ivan Bilić
- Immunology top 5%
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 6
- Immunodeficiency and Autoimmune Disorders 4
- Hematology top 10%
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 4
-
- Epigenetics and DNA Methylation 3
- Biochemical and Molecular Research 2
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
Ivan Bilić
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Immunology 786
- Hematology 134
- Oncology 256
- Molecular Biology 572
- Genetics 88
Countries citing papers authored by Ivan Bilić
This map shows the geographic impact of Ivan Bilić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Bilić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Bilić more than expected).
Fields of papers citing papers by Ivan Bilić
This network shows the impact of papers produced by Ivan Bilić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Bilić. The network helps show where Ivan Bilić may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ivan Bilić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 138 | |
| 6 | 2020 | 1 | |
| 7 | 2017 | 18 | |
| 8 | Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor. | 2016 | 10 |
| 9 | Obesity and cancer | 2014 | 1 |
| 10 | 2014 | 91 | |
| 11 | 2013 | 77 | |
| 12 | 2012 | 3 | |
| 13 | 2012 | 161 | |
| 14 | 2010 | 83 | |
| 15 | 2008 | 216 | |
| 16 | 2007 | 10 | |
| 17 | 2006 | 45 | |
| 18 | 2006 | 84 | |
| 19 | 2005 | 33 | |
| 20 | 1999 | 23 |
About Ivan Bilić
Ivan Bilić is a scholar working on Immunology, Genetics and Oncology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Immunology (786 citations), Hematology (134 citations) and Oncology (256 citations). Ivan Bilić has collaborated with scholars based in Austria, Croatia and Germany. Frequent co-authors include Meinrad Busslinger, Wilfried Ellmeier, Qiong Sun, Markus Jaritz, Caroline Hutter, César Cobaleda, Stephen Malin, Hiromi Tagoh, Bojan Vilagos and Bernd Unger. Their work appears in journals such as The Journal of Immunology, Blood, The Journal of Experimental Medicine, Immunology Letters and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.